D-0005-2022 Class II Ongoing
FDA drug recall D-0005-2022 was initiated by RISING PHARMACEUTICALS on Sep 2, 2021 and is designated Class II. Reason for recall: Labeling: Incorrect Instructions The recall status is ongoing. Affected quantity: 1,344 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 13, 2021
- Initiation Date
- Sep 2, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,344 bottles
Product description
Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01
Reason for recall
Labeling: Incorrect Instructions
Distribution pattern
to be entered
Code information
Lot # CB21024, Exp 2/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0005-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026